Fascial Closure Technique After Gynecologic Laparoscopic Surgery and Postoperative Pain
Pain, Postoperative

About this trial
This is an interventional treatment trial for Pain, Postoperative
Eligibility Criteria
Inclusion Criteria:
- Patients aged 18 or older.
- Any patient undergoing laparoscopic gynecologic surgery with one left upper quadrant port site > 10 mm via either robotic or traditional laparoscopic techniques for any indication including abnormal bleeding, pelvic pain, gynecologic cancer, uterine fibroids, etc. Procedures performed will include but not be limited to hysterectomy, bilateral or unilateral salpingoophorectomy, ovarian cystectomy, and pelvic floor support procedures.
- Patients willing and able to give informed consent.
- Patients capable and willing to return for follow up and complete pain diaries.
Exclusion Criteria:
- Patients unable to return for follow up.
- Patients undergoing laparoscopic surgery that requires conversion to laparotomy.
- Patients undergoing laparoscopic surgery that does not require a port site >10 mm.
Sites / Locations
- Erlanger Baroness Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Traditional Direct Fascial Closure
Fascial Closure Device
At the beginning of the laparoscopic procedure, all patients will receive 5 mL of 0.5% ropivacaine into each laparoscopic incision site. Patients in this group will have fascia closed under traditional direct visualization without laparoscopic guidance using a single interrupted suture of 0-vicryl.
At the beginning of the laparoscopic procedure, all patients will receive 5 mL of 0.5% ropivacaine into each laparoscopic incision site. Patients in this group will have fascia closed using direct laparscopic visualization with the Carter-Thomason fascial closure device with a single interrupted suture of 0-vicryl.